InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma is a dataset published in PLoS ONE (2023). On theSindex it has a DataRank of 0.386, placing it in the top 47% of the data-sharing corpus. It has been cited 10 times, with 2 citing works in its 1-hop citation network.
Ranks in the top 47% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0.0267
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
National Institute of General Medical Sciences
Grant: 1T32GM135128
Foundation for the National Institutes of Health
Grant: K08CA151645
NCI NIH HHS
Grant: R01 CA121118
NIGMS NIH HHS
Grant: T32 GM135128
Foundation for the National Institutes of Health
Grant: P01CA206980
Foundation for the National Institutes of Health
Grant: P30CA118100
Foundation for the National Institutes of Health
Grant: P50 CA225450
Australian Research Council
Grant: 2008454
Australian Research Council
Grant: APP1141295
NCI NIH HHS
Grant: P30 CA042014
NCI NIH HHS
Grant: R21 CA245577
Foundation for the National Institutes of Health
Grant: P30CA016087
Australian Research Council
Grant: 1174325
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R01CA121118-14
A High-Throughput Model for Human Melanoma
National Institutes of Health
Grant: 5R21CA245577-02
Development of a new molecular predictor for risk of distant metastases in melanoma
National Institutes of Health
Grant: 3P01CA206980-02S2
Genomic Evaluation of the Female Survival Advantages in Melanoma
National Institutes of Health
Grant: 3P30CA118100-18S1
University of New Mexico Cancer Center Support Grant
National Institutes of Health
Grant: 5P50CA225450-04
NYU Melanoma SPORE
National Institutes of Health
Grant: 5P30CA016087-32
Experimental Pathology
National Institutes of Health
Grant: 5T32GM135128-05
NRSA in Genetics
National Institutes of Health
Grant: 5K08CA151645-02
Prognostic markers in metastatic melanoma
National Health and Medical Research Council (NHMRC)
Grant: 1141295
Improving clinical outcomes of melanoma patients
National Institutes of Health
Grant: 3P30CA042014-30S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5P30CA118100-05
CANCER CENTER RESEARCH ADMINISTRATION
The Ainsworth Foundation
the Huntsman Foundation
Roswell Park Alliance Foundation, Roswell Park Cancer Institute
The Marit Peterson Fund for Melanoma Research
University of Texas MD Anderson Cancer Center Miriam and Jim Mulva Research Fund
Faculty of Medicine and Health, University of Sydney
The McCarthy Skin Cancer Research Fund
Cleveland Foundation
Robert E. Leet and Clara Guthrie Patterson Trust
Royal Prince Alfred Hospital
ClearBridge Foundation
Cycle for Survival
Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Char and Chuck Fowler Family Foundation
Melanoma Institute Australia
The Cameron Family
The Irving and Nadine Mansfield and Robert David Levitt Cancer Research Chair
FWCI
1.03
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals